138 related articles for article (PubMed ID: 31910639)
1. Correlation of Nasal Fluid Biomarkers and Symptoms in Patients with Persistent Allergic Rhinitis.
Kim SI; Kwon OE; Park JM; Doo JG; Kim SH; Jung HR; Min JY; Kim SW; Lee YC; Eun YG
Ann Otol Rhinol Laryngol; 2020 Jun; 129(6):542-547. PubMed ID: 31910639
[TBL] [Abstract][Full Text] [Related]
2. Measurement of Tryptase and CC16/Albumin in Nasal Lavage Fluid as a Screening Tool of Allergic Rhinitis.
Kwon OE; Lee YC; Park JM; Kim SW; Eun YG; Ko SG
Am J Rhinol Allergy; 2021 Nov; 35(6):768-773. PubMed ID: 33631947
[TBL] [Abstract][Full Text] [Related]
3. Nasal epithelium biomarkers in young children: associations with allergic sensitization and environmental stressors.
Sardella A; Voisin C; Dumont X; Marcucci F; Bernard A
Pediatr Pulmonol; 2013 Jun; 48(6):571-8. PubMed ID: 23169618
[TBL] [Abstract][Full Text] [Related]
4. Low levels of CC16 in nasal fluid of children with birch pollen-induced rhinitis.
Johansson S; Keen C; Ståhl A; Wennergren G; Benson M
Allergy; 2005 May; 60(5):638-42. PubMed ID: 15813809
[TBL] [Abstract][Full Text] [Related]
5. Nasal epithelium integrity, environmental stressors, and allergic sensitization: a biomarker study in adolescents.
Sardella A; Voisin C; Nickmilder M; Dumont X; Annesi-Maesano I; Bernard A
Biomarkers; 2012 Jun; 17(4):309-18. PubMed ID: 22424574
[TBL] [Abstract][Full Text] [Related]
6. The relationship between IL-17A and IL-22 expression and clinical severity in patients with moderate/severe persistent allergic rhinitis.
Shahsavan S; Pirayesh A; Samani OZ; Shirzad H; Zamani MA; Amani S; Kazemi SM; Moghni M; Deris F; Bageri N; Salimzadeh L; Tavakoli G; Arjenaki MG
Am J Otolaryngol; 2019; 40(2):173-178. PubMed ID: 30594402
[TBL] [Abstract][Full Text] [Related]
7. [Nasal soluble levels of ICAM-1 in allergic rhinitis].
Gilain L; Guichard C; Beaujon G; Mom T; Monneyron E; Saleh H; Advenier D; Caillaud D
Ann Otolaryngol Chir Cervicofac; 2000 Mar; 117(2):91-7. PubMed ID: 10739998
[TBL] [Abstract][Full Text] [Related]
8. Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity.
Baumann R; Rabaszowski M; Stenin I; Tilgner L; Gaertner-Akerboom M; Scheckenbach K; Wiltfang J; Chaker A; Schipper J; Wagenmann M
Clin Exp Allergy; 2013 Oct; 43(10):1134-43. PubMed ID: 24074331
[TBL] [Abstract][Full Text] [Related]
9. Inverse relation between nasal fluid Clara Cell Protein 16 levels and symptoms and signs of rhinitis in allergen-challenged patients with intermittent allergic rhinitis.
Benson M; Fransson M; Martinsson T; Naluai AT; Uddman R; Cardell LO
Allergy; 2007 Feb; 62(2):178-83. PubMed ID: 17298427
[TBL] [Abstract][Full Text] [Related]
10. Clara cell protein 16 and eosinophil cationic protein production in chronically inflamed sinonasal mucosa.
Špadijer-Mirković C; Perić A; Belić B; Vojvodić D
Int Forum Allergy Rhinol; 2016 May; 6(5):529-36. PubMed ID: 26833624
[TBL] [Abstract][Full Text] [Related]
11. DMBT1 has a protective effect on allergic rhinitis.
Zhao Y; Tao Q; Wu J; Liu H
Biomed Pharmacother; 2020 Jan; 121():109675. PubMed ID: 31810134
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of high-mobility group box-1 protein 1 (HMGB1)/toll-like receptor (TLR) 4 with nasal interleukins in allergic rhinitis patients.
Zhu X; Cong J; Yang B; Sun Y
Cytokine; 2020 Feb; 126():154880. PubMed ID: 31739216
[TBL] [Abstract][Full Text] [Related]
13. Nasal lavage mediator profile and cellular composition of nasal brushing material during latex challenge tests.
Raulf-Heimsoth M; Wirtz C; Papenfuss F; Baur X
Clin Exp Allergy; 2000 Jan; 30(1):110-21. PubMed ID: 10606938
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of Fas in Moderate/Severe and Mild Persistent Allergic Rhinitis and Its Correlation With Pathological Parameters.
Pirayesh A; Shahsavan S; Zargari Samani O; Shirzad H; Amani S; Zamani MA; Salimzadeh L; Bagheri N; Moghni M; Deris F
Am J Rhinol Allergy; 2019 May; 33(3):286-293. PubMed ID: 30648403
[TBL] [Abstract][Full Text] [Related]
15. Clara cell protein in nasal lavage fluid and nasal nitric oxide - biomarkers with anti-inflammatory properties in allergic rhinitis.
Irander K; Palm JP; Borres MP; Ghafouri B
Clin Mol Allergy; 2012 Feb; 10():4. PubMed ID: 22309677
[TBL] [Abstract][Full Text] [Related]
16. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
[TBL] [Abstract][Full Text] [Related]
17. Effect of posterior nasal neurectomy on the suppression of allergic rhinitis.
Wang L; Chen M; Xu M
Am J Otolaryngol; 2020; 41(3):102410. PubMed ID: 32098705
[TBL] [Abstract][Full Text] [Related]
18. Severe Persistent Allergic Rhinitis. Inflammation but No Histologic Features of Structural Upper Airway Remodeling.
Eifan AO; Orban NT; Jacobson MR; Durham SR
Am J Respir Crit Care Med; 2015 Dec; 192(12):1431-9. PubMed ID: 26378625
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil Chemokines and Clara Cell Protein 16 Production in Nasal Mucosa of Patients with Persistent Allergic Rhinitis.
Perić A; Mirković CŠ; Đurđević BV; Perić AV; Vojvodić D
Eurasian J Med; 2017 Oct; 49(3):178-182. PubMed ID: 29123440
[TBL] [Abstract][Full Text] [Related]
20. Non-allergic, mastocytosis-associated rhinitis.
Dollner R; Taraldsrud E; Iversen K; Osnes T; Kristensen B; Kramer MF
Clin Exp Allergy; 2013 Apr; 43(4):406-12. PubMed ID: 23517036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
